Contact this trialFirst, we need to learn more about you.
Inhaled Imatinib for Pulmonary Arterial Hypertension
Recruiting2 awardsPhase 3
Montréal, Quebec
This trial will study the long-term safety and effectiveness of a medicine, AV-101, for pulmonary arterial hypertension. Subjects will receive one of three doses until the optimal dose is found.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.